US5053512A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
Assignee: RTI International
•
Filing: 1990-04-17
•
Granted: 1991-10-01
•
Expires: 2010-04-17
Abstract
Abstract The invention relates to a method of producing 20(S)-comptothecin, 20(R)-camptothecin and analogs thereof. The method involves the resolution of an mixture of enantiomers of an intermediate lactone.
Inventors
- 👤 Mansukh C. Wani
- 👤 Allan W. Nicholas
- 👤 Monroe E. Wall
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 04:17
CPC Classifications
C; C07; C07D; C07D491/00; C07D491/22
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
260 words
A method for producing substantially pure 20(S)-camptothecin, 20(R)-camptothecin or analogs thereof, comprising the steps of: (a) reacting a mixture of enantiomeric lactones having formula (I), wherein X is an achiral ketal group which upon treatment with-an acid is converted into a keto group, ##STR6## with a substantially enantiomerically pure primary or secondary amine having the formula RR 1 NH, wherein R is an alkyl or aralkyl group containing a single chiral carbon and R 1 is hydrogen or an achiral alkyl, aralkyl or aryl group, to produce a mixture of diastereomeric amides with formula (II) ##STR7## (b) triturating said diastereomeric amide mixture with a non-polar organic solvent whereby a precipitate enriched in the more polar amide of said diastereomeric mixture and a mother liquor enriched in the less polar amide of said diastereomeric amide mixture are formed; (c) separating said precipitate from said mother liquor; (d) treating said precipitated amide with acid, whereby said precipitated amide is lactonized and deprotected to give an enantiomerically enriched ketolactone having formula (III) ##STR8## (e) reacting said ketolactone with an ortho-amino carbonyl compound having the formula ##STR9## wherein n=1 or 2 and R 2 is a member selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, cyano, methylenedioxy, formyl, hydroxy, nitro, amino, amido, chloro, bromo, iodo, fluoro, aminomethyl, trifluoromethyl, azido, and hydrazinyl groups, R 3 is H or C 1-8 alkyl; and R 4 is a side-chain of one of the twenty naturally occurring amino acids, to produce said camptothecin or camptothecin analog; and (f) isolating said camptothecin or camptothecin analog.
Claim 2
Independent Claim
260 words
A method for producing substantially pure 20(S)-camptothecin, 20(R)-camptothecin or analogs thereof, comprising the steps of: (a) reacting a mixture of enantiomeric lactones having formula (I), wherein X is an achiral ketal group which upon treatment with-an acid is converted into a keto group, ##STR6## with a substantially enantiomerically pure primary or secondary amine having the formula RR 1 NH, wherein R is an alkyl or aralkyl group containing a single chiral carbon and R 1 is hydrogen or an achiral alkyl, aralkyl or aryl group, to produce a mixture of diastereomeric amides with formula (II) ##STR7## (b) triturating said diastereomeric amide mixture with a non-polar organic solvent whereby a precipitate enriched in the more polar amide of said diastereomeric mixture and a mother liquor enriched in the less polar amide of said diastereomeric amide mixture are formed; (c) separating said precipitate from said mother liquor; (d) treating said precipitated amide with acid, whereby said precipitated amide is lactonized and deprotected to give an enantiomerically enriched ketolactone having formula (III) ##STR8## (e) reacting said ketolactone with an ortho-amino carbonyl compound having the formula ##STR9## wherein n=1 or 2 and R 2 is a member selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, cyano, methylenedioxy, formyl, hydroxy, nitro, amino, amido, chloro, bromo, iodo, fluoro, aminomethyl, trifluoromethyl, azido, and hydrazinyl groups, R 3 is H or C 1-8 alkyl; and R 4 is a side-chain of one of the twenty naturally occurring amino acids, to produce said camptothecin or camptothecin analog; and (f) isolating said camptothecin or camptothecin analog.
Claim 3
Dependent Claim
25 words
The method of claim 1, wherein said amine is selected from the group consisting of R and S enantiomers of α-methylbenzylamine, α-(1-naphthyl)-ethylamine, α-(2-naphthyl)-ethylamine and amphetamine.
Claim 4
Dependent Claim
12 words
The method of claim 2, wherein said amine is R-α-methylbenzylamine or S-α-methylbenzylamine.
Claim 5
Dependent Claim
26 words
The method of claim 1, wherein said nonpolar organic solvent is selected from the group consisting of aliphatic, aromatic and araliphatic hydrocarbons having 6-20 carbon atoms.
Claim 6
Dependent Claim
12 words
The method of claim 4, wherein said nonpolar organic solvent is toluene.
Claim 7
Dependent Claim
16 words
The method of claim 1, wherein said acid is a mineral acid or an organic acid.
Claim 8
Dependent Claim
12 words
The method of claim 6, wherein said acid is aqueous sulfuric acid.
Claim 9
Dependent Claim
32 words
The method of claim 1, wherein said treating step comprises lactonizing said precipitated amide in the presence of glacial acetic acid, and deprotecting said lactone in the presence of aqueous sulfuric acid.
Claim 10
Dependent Claim
221 words
The method of claim 1, further comprising: (g) concentrating said mother liquor to produce a product enriched in said less polar amide and treating said enriched product with an acid to give an enriched mixture of lactones having formula (I); (h) reacting said enriched mixture of lactones with a second substantially enantiomerically pure amine, wherein said second amine has a configuration opposite that of the amine used in step (a), to give an enriched mixture of diastereomeric amides having formula (II); (i) turating said enriched mixture of diastereomeric amides with a non-polar organic solvent, whereby the more polar amide of said enriched mixture precipitates; (j) separating said enriched precipitate from said non-polar organic solvent; (k) treating said precipitate with an acid, whereby said precipitate is lactonized and deprotected to give a substantially enantiomerically pure ketolactone having formula (III); (l) reacting said ketone with an ortho-amino carbonyl compound having the formula ##STR10## wherein n=1 or 2 and R 2 is a member selected from the group consisting of C 1-8 alkyl, C 1-8 alkoxy, cyano, methylenedioxy, formyl, hydroxy, nitro, amino, amido, chloro, bromo, iodo, fluoro aminomethyl, trimethylamino, azido, and hydrazinyl groups; R 3 is H or C 1-8 alkyl; and R 4 is a side-chain of one of the twenty naturally occurring amino acids; and (m) isolating said camptothecin or camptothecin analog.
Claim 11
Dependent Claim
7 words
The substantially pure 20(S)-camptothecin which is 10,11-methylenediox-20(S)-camptothecin.
Claim 12
Dependent Claim
7 words
The substantially pure 20(S)-camptothecin which is 10,11-methylenediox-20(S)-camptothecin.
Claim 13
Dependent Claim
11 words
The 20(S)-camptothecin of claim 10, having an optical purity of 75-100%.
Claim 14
Dependent Claim
11 words
The 20(S)-camptothecin of claim 11, having an optical purity of 95-100%.
References Cited (Backward Citations)
US4031098A
Cited
EP0074256A1
Cited
US4473692A
Cited
US4545880A
Cited
JPS595188A
Cited
JPS5951287A
Cited
JPS5951289A
Cited
US4604463A
Cited
JPS6150985A
Cited
JPS6185389A
Cited
JPS6185319A
Cited
EP0220601A1
Cited
US4778891A
Cited
US4894456A
Cited
US4981968A
Cited
US4914205A
Cited
US4943579A
Cited
EP0321122A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-30 | 1995-04-01 | 1995-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-30 | 1999-04-01 | 1999-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-30 | 2003-04-01 | 2003-10-01 | $7700.00 | Window Closed / Lapsed |